Dr. Daniel holds a degree of molecular biology (Bsc.) and a PhD in biotechnology. The research project for his PhD studies focused on genetic modification of hamster cells to increase therapeutic recombinant protein production.
During the final years of studies, he became increasingly interested in human genetics, so that by the year 2009, he founded his first company Novogenia GmbH in Austria. The Novogenia group of companies became the European market leader in lifestyle genetic testing, extended newborn screening in the private sector, and pioneered preventive personal genomics. Dr. Wallerstorfer co-founded Rootine to bring his expertise to the US market:
Genetic testing technologies and development | Laboratory automation | Metabolite analysis of urine using GCMS | Laboratory software development | Human genetics, disease risks and genetic traits | Nutrigenetics and weight management | Micronutrient requirement and response through genetics | Genetic prevention/action program development | Supplement production